5MY4 | Immune System | date | Jan 25, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of Pyroglutamate-Abeta-Specific Fab C#17 In Comple Human Abeta-Pe3-12pegb | ||||||||||||||
authors | C.Parthier, A.Piechotta, M.T.Stubbs | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Fab C#17 Light Chain Chain: A Engineered: Yes |
Organism_scientific: Mus Musculus Organism_taxid: 10090 Expression_system: Mus Musculus Expression_system_taxid: 10090 | ||||||||||||||
Molecule: Fab C#17 Heavy Chain Chain: B Engineered: Yes |
Organism_scientific: Mus Musculus Organism_taxid: 10090 Expression_system: Mus Musculus Expression_system_taxid: 10090 | ||||||||||||||
Molecule: Pyroglutamate-Abeta Pe3-12-Pegb Chain: C Engineered: Yes |
Synthetic: Yes Organism_scientific: Homo Sapiens Organism_taxid: 9606 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.21 Å | ||||||||||||
ligand | PCA | enzyme |
| ||||||||||||
Primary reference | Structural and functional analyses of pyroglutamate-amyloid-beta-specific antibodies as a basis for Alzheimer immunotherapy., Piechotta A, Parthier C, Kleinschmidt M, Gnoth K, Pillot T, Lues I, Demuth HU, Schilling S, Rahfeld JU, Stubbs MT, J Biol Chem. 2017 Jul 28;292(30):12713-12724. doi: 10.1074/jbc.M117.777839. Epub , 2017 Jun 16. PMID:28623233 |
Data retrieval |
View 5MY4 in 3D |
Visual 3D analysis of 5MY4 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5MY4 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |